Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Recombinant NAPc2 nematode anticoagulant protein data

At the Transcatheter Cardiovascular Therapeutics conference in Washington, CVAS presented positive results

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE